{"entity":{"type":"insider","cik":"0001969082","url":"/insider/0001969082","json_url":"/insider/0001969082.json","name":"Cislini Jeff","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":31,"first":"2023-06-22","last":"2026-06-18","span_basis":"filed_date"},"name_variants":[{"name":"Cislini Jeff","source":"filing","n_filings":31,"first_seen":"2023-06-22","last_seen":"2026-06-18"}],"transactions":[{"id":5824884,"accession":"0001610717-26-000245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-26-000245","line_url":"/filing/0001610717-26-000245#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2157.0,"shares_display":"2,157","price_per_share":156.1191,"price_display":"156.12","price_state":"stated","total_value":336748.8987,"total_display":"336,748.90","shares_owned_after":56521.0,"shares_owned_after_display":"56,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-18","scope":"insider"},{"id":5863062,"accession":"0001610717-26-000127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-26-000127","line_url":"/filing/0001610717-26-000127#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1163.0,"shares_display":"1,163","price_per_share":97.44,"price_display":"97.44","price_state":"stated","total_value":113322.72,"total_display":"113,322.72","shares_owned_after":58518.0,"shares_owned_after_display":"58,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-19","filed_date":"2026-03-19","scope":"insider"},{"id":5863060,"accession":"0001610717-26-000127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-26-000127","line_url":"/filing/0001610717-26-000127#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1795.0,"shares_display":"1,795","price_per_share":99.4804,"price_display":"99.48","price_state":"stated","total_value":178567.318,"total_display":"178,567.32","shares_owned_after":59681.0,"shares_owned_after_display":"59,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":5824871,"accession":"0001610717-26-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-26-000018","line_url":"/filing/0001610717-26-000018#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":908.0,"shares_display":"908","price_per_share":115.6,"price_display":"115.60","price_state":"stated","total_value":104964.8,"total_display":"104,964.80","shares_owned_after":46976.0,"shares_owned_after_display":"46,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-21","filed_date":"2026-01-23","scope":"insider"},{"id":4675429,"accession":"0001610717-25-000424","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000424","line_url":"/filing/0001610717-25-000424#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2688.0,"shares_display":"2,688","price_per_share":76.8169,"price_display":"76.82","price_state":"stated","total_value":206483.8272,"total_display":"206,483.83","shares_owned_after":47884.0,"shares_owned_after_display":"47,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-16","filed_date":"2025-12-18","scope":"insider"},{"id":4896437,"accession":"0001610717-25-000383","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-25-000383","line_url":"/filing/0001610717-25-000383#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13388.0,"shares_display":"13,388","price_per_share":70.138,"price_display":"70.14","price_state":"stated","total_value":939007.544,"total_display":"939,007.54","shares_owned_after":50425.0,"shares_owned_after_display":"50,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-20","scope":"insider"},{"id":4928125,"accession":"0001610717-25-000368","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-25-000368","line_url":"/filing/0001610717-25-000368#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":660000.0,"total_display":"660,000.00","shares_owned_after":50425.0,"shares_owned_after_display":"50,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-17","filed_date":"2025-10-20","scope":"insider"},{"id":4365897,"accession":"0001610717-25-000353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000353","line_url":"/filing/0001610717-25-000353#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1799.0,"shares_display":"1,799","price_per_share":44.26,"price_display":"44.26","price_state":"stated","total_value":79623.74,"total_display":"79,623.74","shares_owned_after":50425.0,"shares_owned_after_display":"50,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-24","filed_date":"2025-09-26","scope":"insider"},{"id":4204280,"accession":"0001610717-25-000347","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000347","line_url":"/filing/0001610717-25-000347#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1869.0,"shares_display":"1,869","price_per_share":45.8249,"price_display":"45.82","price_state":"stated","total_value":85646.7381,"total_display":"85,646.74","shares_owned_after":52224.0,"shares_owned_after_display":"52,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-16","filed_date":"2025-09-18","scope":"insider"},{"id":4928110,"accession":"0001610717-25-000250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000250","line_url":"/filing/0001610717-25-000250#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1912.0,"shares_display":"1,912","price_per_share":39.6108,"price_display":"39.61","price_state":"stated","total_value":75735.8496,"total_display":"75,735.85","shares_owned_after":54093.0,"shares_owned_after_display":"54,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-06-23","scope":"insider"},{"id":4475317,"accession":"0001610717-25-000240","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000240","line_url":"/filing/0001610717-25-000240#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1878.0,"shares_display":"1,878","price_per_share":39.83,"price_display":"39.83","price_state":"stated","total_value":74800.74,"total_display":"74,800.74","shares_owned_after":56005.0,"shares_owned_after_display":"56,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-18","scope":"insider"},{"id":5053799,"accession":"0001610717-25-000088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000088","line_url":"/filing/0001610717-25-000088#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2041.0,"shares_display":"2,041","price_per_share":38.7105,"price_display":"38.71","price_state":"stated","total_value":79008.1305,"total_display":"79,008.13","shares_owned_after":57723.0,"shares_owned_after_display":"57,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-24","scope":"insider"},{"id":4896415,"accession":"0001610717-25-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000081","line_url":"/filing/0001610717-25-000081#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1458.0,"shares_display":"1,458","price_per_share":39.0403,"price_display":"39.04","price_state":"stated","total_value":56920.7574,"total_display":"56,920.76","shares_owned_after":59764.0,"shares_owned_after_display":"59,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":4969176,"accession":"0001610717-25-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000012","line_url":"/filing/0001610717-25-000012#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2406.0,"shares_display":"2,406","price_per_share":40.5,"price_display":"40.50","price_state":"stated","total_value":97443.0,"total_display":"97,443.00","shares_owned_after":39222.0,"shares_owned_after_display":"39,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-22","scope":"insider"},{"id":2122445,"accession":"0001610717-24-000544","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000544","line_url":"/filing/0001610717-24-000544#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1599.0,"shares_display":"1,599","price_per_share":45.4038,"price_display":"45.40","price_state":"stated","total_value":72600.6762,"total_display":"72,600.68","shares_owned_after":41628.0,"shares_owned_after_display":"41,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-18","scope":"insider"},{"id":2511733,"accession":"0001610717-24-000525","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000525","line_url":"/filing/0001610717-24-000525#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2554.0,"shares_display":"2,554","price_per_share":55.1337,"price_display":"55.13","price_state":"stated","total_value":140811.4698,"total_display":"140,811.47","shares_owned_after":43080.0,"shares_owned_after_display":"43,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-15","filed_date":"2024-11-19","scope":"insider"},{"id":2647001,"accession":"0001610717-24-000518","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-24-000518","line_url":"/filing/0001610717-24-000518#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":360000.0,"total_display":"360,000.00","shares_owned_after":45634.0,"shares_owned_after_display":"45,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-06","filed_date":"2024-11-08","scope":"insider"},{"id":2703382,"accession":"0001610717-24-000506","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-24-000506","line_url":"/filing/0001610717-24-000506#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":50.1711,"price_display":"50.17","price_state":"stated","total_value":301026.6,"total_display":"301,026.60","shares_owned_after":45634.0,"shares_owned_after_display":"45,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-11","filed_date":"2024-10-15","scope":"insider"},{"id":2646987,"accession":"0001610717-24-000485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000485","line_url":"/filing/0001610717-24-000485#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1454.0,"shares_display":"1,454","price_per_share":44.1853,"price_display":"44.19","price_state":"stated","total_value":64245.4262,"total_display":"64,245.43","shares_owned_after":45634.0,"shares_owned_after_display":"45,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-18","scope":"insider"},{"id":3260937,"accession":"0001610717-24-000395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000395","line_url":"/filing/0001610717-24-000395#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2399.0,"shares_display":"2,399","price_per_share":40.83,"price_display":"40.83","price_state":"stated","total_value":97951.17,"total_display":"97,951.17","shares_owned_after":47088.0,"shares_owned_after_display":"47,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-09","filed_date":"2024-07-10","scope":"insider"},{"id":2829016,"accession":"0001610717-24-000368","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000368","line_url":"/filing/0001610717-24-000368#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":38.4698,"price_display":"38.47","price_state":"stated","total_value":76939.6,"total_display":"76,939.60","shares_owned_after":49487.0,"shares_owned_after_display":"49,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-26","filed_date":"2024-06-27","scope":"insider"},{"id":2290717,"accession":"0001610717-24-000348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000348","line_url":"/filing/0001610717-24-000348#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1757.0,"shares_display":"1,757","price_per_share":37.3874,"price_display":"37.39","price_state":"stated","total_value":65689.6618,"total_display":"65,689.66","shares_owned_after":51487.0,"shares_owned_after_display":"51,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-20","scope":"insider"},{"id":2324909,"accession":"0001610717-24-000256","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-24-000256","line_url":"/filing/0001610717-24-000256#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":39.5061,"price_display":"39.51","price_state":"stated","total_value":31604.88,"total_display":"31,604.88","shares_owned_after":52874.0,"shares_owned_after_display":"52,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-21","filed_date":"2024-05-22","scope":"insider"},{"id":2324906,"accession":"0001610717-24-000256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000256","line_url":"/filing/0001610717-24-000256#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":38.6657,"price_display":"38.67","price_state":"stated","total_value":27065.99,"total_display":"27,065.99","shares_owned_after":53674.0,"shares_owned_after_display":"53,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-21","filed_date":"2024-05-22","scope":"insider"},{"id":2823787,"accession":"0001610717-24-000189","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-24-000189","line_url":"/filing/0001610717-24-000189#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":31.515,"price_display":"31.52","price_state":"stated","total_value":25212.0,"total_display":"25,212.00","shares_owned_after":54374.0,"shares_owned_after_display":"54,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-28","scope":"insider"},{"id":2823782,"accession":"0001610717-24-000189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000189","line_url":"/filing/0001610717-24-000189#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":30.3843,"price_display":"30.38","price_state":"stated","total_value":21269.01,"total_display":"21,269.01","shares_owned_after":55174.0,"shares_owned_after_display":"55,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-28","scope":"insider"},{"id":2731917,"accession":"0001610717-24-000174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000174","line_url":"/filing/0001610717-24-000174#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1252.0,"shares_display":"1,252","price_per_share":31.5832,"price_display":"31.58","price_state":"stated","total_value":39542.1664,"total_display":"39,542.17","shares_owned_after":55874.0,"shares_owned_after_display":"55,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-18","filed_date":"2024-03-20","scope":"insider"},{"id":2363469,"accession":"0001610717-24-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000040","line_url":"/filing/0001610717-24-000040#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":40500.0,"total_display":"40,500.00","shares_owned_after":36126.0,"shares_owned_after_display":"36,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-24","scope":"insider"},{"id":8129388,"accession":"0001610717-23-000414","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-23-000414","line_url":"/filing/0001610717-23-000414#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1229.0,"shares_display":"1,229","price_per_share":25.9017,"price_display":"25.90","price_state":"stated","total_value":31833.1893,"total_display":"31,833.19","shares_owned_after":37284.0,"shares_owned_after_display":"37,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-20","scope":"insider"},{"id":8592958,"accession":"0001610717-23-000360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-23-000360","line_url":"/filing/0001610717-23-000360#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":21.6966,"price_display":"21.70","price_state":"stated","total_value":32544.9,"total_display":"32,544.90","shares_owned_after":38513.0,"shares_owned_after_display":"38,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-20","scope":"insider"},{"id":8509662,"accession":"0001610717-23-000300","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-23-000300","line_url":"/filing/0001610717-23-000300#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1798.0,"shares_display":"1,798","price_per_share":28.0999,"price_display":"28.10","price_state":"stated","total_value":50523.6202,"total_display":"50,523.62","shares_owned_after":40215.0,"shares_owned_after_display":"40,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-10-02","scope":"insider"},{"id":8509659,"accession":"0001610717-23-000300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-23-000300","line_url":"/filing/0001610717-23-000300#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":202.0,"shares_display":"202","price_per_share":29.0599,"price_display":"29.06","price_state":"stated","total_value":5870.0998,"total_display":"5,870.10","shares_owned_after":40013.0,"shares_owned_after_display":"40,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-10-02","scope":"insider"},{"id":8376432,"accession":"0001610717-23-000293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-23-000293","line_url":"/filing/0001610717-23-000293#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1214.0,"shares_display":"1,214","price_per_share":31.3106,"price_display":"31.31","price_state":"stated","total_value":38011.0684,"total_display":"38,011.07","shares_owned_after":42013.0,"shares_owned_after_display":"42,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-20","scope":"insider"},{"id":8237616,"accession":"0001610717-23-000219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-23-000219","line_url":"/filing/0001610717-23-000219#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":26.02,"price_display":"26.02","price_state":"stated","total_value":39030.0,"total_display":"39,030.00","shares_owned_after":43227.0,"shares_owned_after_display":"43,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-31","filed_date":"2023-08-01","scope":"insider"},{"id":8305817,"accession":"0001610717-23-000192","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-23-000192","line_url":"/filing/0001610717-23-000192#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001969082","owner_name":"Cislini Jeff","owner_url":"/insider/0001969082","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1239.0,"shares_display":"1,239","price_per_share":25.14,"price_display":"25.14","price_state":"stated","total_value":31148.46,"total_display":"31,148.46","shares_owned_after":44727.0,"shares_owned_after_display":"44,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":35,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001628171","name":"Revolution Medicines, Inc.","url":"/issuer/0001628171","role":"Officer (General Counsel)","n_filings":31,"first_seen":"2023-06-22","last_seen":"2026-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001969082","retrieved_at":"2026-08-20T21:52:23+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}